<VariationArchive VariationID="183759" VariationName="NM_000077.5(CDKN2A):c.335_337dup (p.Arg112dup)" VariationType="Duplication" Accession="VCV000183759" Version="21" RecordType="classified" NumberOfSubmissions="6" NumberOfSubmitters="6" DateLastUpdated="2024-05-08" DateCreated="2016-07-24" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="182930" VariationID="183759">
      <GeneList>
        <Gene Symbol="CDKN2A" FullName="cyclin dependent kinase inhibitor 2A" GeneID="1029" HGNC_ID="HGNC:1787" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9p21.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="21967752" stop="21995324" display_start="21967752" display_stop="21995324" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="21967750" stop="21994489" display_start="21967750" display_stop="21994489" Strand="-" />
          </Location>
          <OMIM>600160</OMIM>
          <Haploinsufficiency last_evaluated="2022-03-18" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CDKN2A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-03-18" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CDKN2A">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000077.5(CDKN2A):c.335_337dup (p.Arg112dup)</Name>
      <CanonicalSPDI>NC_000009.12:21971021:GACG:GACGACG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>9p21.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="21971021" stop="21971022" display_start="21971021" display_stop="21971022" variantLength="3" positionVCF="21971021" referenceAlleleVCF="A" alternateAlleleVCF="AGAC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="21971020" stop="21971021" display_start="21971020" display_stop="21971021" variantLength="3" positionVCF="21971020" referenceAlleleVCF="A" alternateAlleleVCF="AGAC" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.21971022_21971024dup" Assembly="GRCh37">
            <Expression>NC_000009.11:g.21971022_21971024dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.21971023_21971025dup" Assembly="GRCh38">
            <Expression>NC_000009.12:g.21971023_21971025dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007485.1" sequenceAccession="NG_007485" sequenceVersion="1" change="g.28468_28470dup">
            <Expression>NG_007485.1:g.28468_28470dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000077.5" sequenceAccession="NM_000077" sequenceVersion="5" change="c.335_337dup" MANESelect="true">
            <Expression>NM_000077.5:c.335_337dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000068.1" sequenceAccession="NP_000068" sequenceVersion="1" change="p.Arg112dup">
            <Expression>NP_000068.1:p.Arg112dup</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001195132.2" sequenceAccession="NM_001195132" sequenceVersion="2" change="c.335_337dup">
            <Expression>NM_001195132.2:c.335_337dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001182061.1" sequenceAccession="NP_001182061" sequenceVersion="1" change="p.Arg112dup">
            <Expression>NP_001182061.1:p.Arg112dup</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001363763.2" sequenceAccession="NM_001363763" sequenceVersion="2" change="c.182_184dup">
            <Expression>NM_001363763.2:c.182_184dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001350692.1" sequenceAccession="NP_001350692" sequenceVersion="1" change="p.Arg61dup">
            <Expression>NP_001350692.1:p.Arg61dup</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_058195.4" sequenceAccession="NM_058195" sequenceVersion="4" change="c.378_380dup" MANEPlusClinical="true">
            <Expression>NM_058195.4:c.378_380dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_478102.2" sequenceAccession="NP_478102" sequenceVersion="2" change="p.Ser127dup">
            <Expression>NP_478102.2:p.Ser127dup</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_058197.5" sequenceAccession="NM_058197" sequenceVersion="5" change="c.*258_*260dup">
            <Expression>NM_058197.5:c.*258_*260dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_11" sequenceAccession="LRG_11">
            <Expression>LRG_11:g.28468_28470dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_11t1" sequenceAccession="LRG_11t1">
            <Expression>LRG_11t1:c.335_337dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_11p1" sequenceAccession="LRG_11p1" change="p.Arg112dup">
            <Expression>LRG_11p1:p.Arg112dup</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000077.4" sequenceAccession="NM_000077" sequenceVersion="4" change="c.335_337dupGTC">
            <Expression>NM_000077.4:c.335_337dupGTC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA186348" DB="ClinGen" />
        <XRef Type="rs" ID="768966657" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000077.5(CDKN2A):c.335_337dup (p.Arg112dup) AND Hereditary cancer-predisposing syndrome" Accession="RCV000162477" Version="9">
        <ClassifiedConditionList TraitSetID="13598">
          <ClassifiedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-02-26" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000077.5(CDKN2A):c.335_337dup (p.Arg112dup) AND Familial melanoma" Accession="RCV000232355" Version="9">
        <ClassifiedConditionList TraitSetID="13761">
          <ClassifiedCondition DB="MedGen" ID="C1512419">Familial melanoma</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000077.5(CDKN2A):c.335_337dup (p.Arg112dup) AND not provided" Accession="RCV000237004" Version="8">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-07-21" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000077.5(CDKN2A):c.335_337dup (p.Arg112dup) AND Melanoma and neural system tumor syndrome" Accession="RCV003474844" Version="1">
        <ClassifiedConditionList TraitSetID="2590">
          <ClassifiedCondition DB="MedGen" ID="C1835042">Melanoma and neural system tumor syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-07-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-26" NumberOfSubmissions="6" NumberOfSubmitters="6" DateCreated="2016-07-24" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10498896</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">10922411</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11156381</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11319798</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12072543</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15146471</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16905682</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17047042</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20526219</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24935963</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25803691</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25813228</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27287845</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30291219</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8213823</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8653684</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">865368</ID>
        </Citation>
        <DescriptionHistory Dated="2024-02-11">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="13598" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary Cancer Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary neoplastic syndrome</ElementValue>
                <XRef ID="MONDO:0015356" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19921" />
                <XRef ID="19921" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <Citation Type="general" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet" />
              <XRef ID="C0027672" DB="MedGen" />
              <XRef ID="D009386" DB="MeSH" />
              <XRef ID="MONDO:0015356" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2590" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5472" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Melanoma astrocytoma syndrome</ElementValue>
                <XRef ID="Melanoma+astrocytoma+syndrome/4577" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Melanoma and neural system tumor syndrome</ElementValue>
                <XRef ID="MONDO:0007967" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8468" />
                <XRef ID="8468" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="CAPS, 2013">
                <ID Source="pmc">3585492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="general" Abbrev="CAPS, 2020">
                <ID Source="PubMed">31672839</ID>
                <ID Source="pmc">7295005</ID>
              </Citation>
              <XRef ID="252206" DB="Orphanet" />
              <XRef ID="C1835042" DB="MedGen" />
              <XRef ID="MONDO:0007967" DB="MONDO" />
              <XRef Type="MIM" ID="155755" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="13761" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18483" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hereditary melanoma</ElementValue>
                <XRef ID="C8498" DB="NCI" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary cutaneous melanoma</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Familial melanoma</ElementValue>
                <XRef ID="MONDO:0018961" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3460" />
                <XRef ID="3460" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2022">
                <URL>https://www.nice.org.uk/guidance/ng14</URL>
                <CitationText>UK NICE Guideline NG14, Melanoma: assessment and management, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2023">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/cutaneous_melanoma.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN GuidelinesÂ®) Melanoma: Cutaneous, 2023</CitationText>
              </Citation>
              <XRef ID="618" DB="Orphanet" />
              <XRef ID="C1512419" DB="MedGen" />
              <XRef ID="MONDO:0018961" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7865311" SubmissionDate="2023-12-07" DateLastUpdated="2023-12-30" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000077.5:c.335_337dup|OMIM:155755" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004212529" DateUpdated="2023-12-30" DateCreated="2023-12-30" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-07-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000077.5:c.335_337dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="155755" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2657335" SubmissionDate="2022-01-07" DateLastUpdated="2022-01-08" DateCreated="2020-06-22">
        <ClinVarSubmissionID localKey="Db4KrQBSZeoE7-orUyypkSZWSCdB8nifiEYXSEP13HQ|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001349019" DateUpdated="2022-01-08" DateCreated="2020-06-22" Type="SCV" Version="2" SubmitterName="Color Diagnostics, LLC DBA Color Health" OrgID="505849" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-05-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant is a 3 nucleotide duplication located in exon 2 of the CDKN2A (p16INK4A) gene, creating a single amino acid duplication in the CDKN2A protein. Functional studies have shown that this variant impairs the binding to CDK4 and CDK6 in vitro (PMID: 10498896, 10922411). This variant has been reported in individuals affected with melanoma and is a frequently observed mutation in melanoma-prone families from Northern Europe (PMID: 8653684, 9168184, 10922411, 11156381, 11319798, 12072543, 16905682, 15146471, 17047042, 20526219, 24935963, 25803691, 25813228, 8653684, 9168184, 11319798). It has been shown that this variant segregates with disease and is reported as a Swedish founder mutation in melanoma-prone families (PMID: 8653684, 9168184, 11319798). Carrier families are also prone to non-melanoma cancer including breast and pancreatic carcinomas (PMID: 10922411, 15146471, 17047042, 24935963). This variant has been identified in 3/238418 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Based on the available evidence, this variant is classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>NGS</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CDKN2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000077.4:c.335_337dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>Color Genomics - ClinVar Submission - May2020 - SUB747</SubmissionName>
          <SubmissionName>SUB10906337</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="561381" SubmissionDate="2022-10-05" DateLastUpdated="2023-03-04" DateCreated="2016-07-24">
        <ClinVarSubmissionID localKey="GDXSV:242791" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000292539" DateUpdated="2023-03-04" DateCreated="2016-07-24" Type="SCV" Version="8" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-07-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>In-frame insertion of 1 amino acid located in the critical ANK 4 repeat (UniProt); Identified in several malignant melanoma families and published as a Swedish founder pathogenic variant (Borg et al., 1996; Platz et al., 1997; Borg et al., 2000; Hashemi et al., 2000; Hashemi et al., 2001; Goldstein et al., 2006; Helgadottir et al., 2014; Helgadottir et al., 2020); Case control studies suggest this variant is associated with increased risk for melanoma, pancreatic cancer, and possibly other cancers (Helgadottir et al., 2014); Published functional studies demonstrate a damaging effect: inability to bind CDK4 and CDK6 (Ruas et al., 1999; Borg et al., 2000); Not observed at significant frequency in large population cohorts (gnomAD); Also known as 113insArg and c.337-338insGTC; This variant is associated with the following publications: (PMID: 10498896, 10922411, 9168184, 10338331, 16905682, 8653684, 24935963, 12072543, 17047042, 15146471, 19077144, 11319798, 11156381, 27287845, 29215650, 33076392, 33945383, 33766116, 30291219, 29922827)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CDKN2A" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:11938</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000077.4:c.335_337dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_133_20221005054204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_50_20210924044205</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_80_20220112054204</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7910661" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2024-02-04">
        <ClinVarSubmissionID localKey="d99555cb9f56c6fd53f85cb31f595ef37a7347c25f848bf1582533bebf821a68|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004234501" DateUpdated="2024-02-04" DateCreated="2024-02-04" Type="SCV" Version="1" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-06-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000077.4:c.335_337dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="538667" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2016-07-01">
        <ClinVarSubmissionID localKey="434468|MedGen:C1512419" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000283443" DateUpdated="2024-02-14" DateCreated="2016-07-01" Type="SCV" Version="10" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">8213823</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8653684</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11319798</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24935963</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30291219</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">865368</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11319798</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10922411</ID>
          </Citation>
          <Comment>The CDKN2A gene encodes two different proteins, p16INK4a and p14ARF, which are translated from alternative transcripts with different open reading frames. Both transcripts have been analyzed. We report either the variant with the higher classification or default to the CDKN2A (p16INK4a) variant. This report therefore includes the details for the CDKN2A (p16INK4a) variant. This variant, c.335_337dup, results in the insertion of 1 amino acid(s) of the CDKN2A (p16INK4a) protein (p.Arg112dup), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs768966657, gnomAD 0.003%). This variant has been observed in individuals with melanoma and/or pancreatic cancer (PMID: 8213823, 8653684, 11319798, 24935963, 30291219; Invitae). It is commonly reported in individuals of Swedish ancestry (PMID: 865368, 11319798). This variant is also known as 113insR, 113insArg, p.R112_L113insR, 112-113insArg, c.337_338insGTC in the CDKN2A (p16INK4a) transcript, and c.378_380dup (p.Ser127dup) in the CDKN2A (p14ARF) transcript. ClinVar contains an entry for this variant (Variation ID: 183759). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this variant affects CDKN2A (p16INK4a) function (PMID: 10922411). For these reasons, this variant has been classified as Pathogenic. While the evidence indicates that this variant confers risk of developing CDKN2A (p16INK4a)-associated conditions, its association with risk for developing CDKN2A (p14ARF)-associated conditions is still unclear.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CDKN2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.21971020_21971021insGAC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1512419" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="383849" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2015-03-24">
        <ClinVarSubmissionID localKey="a0051|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000212850" DateUpdated="2024-05-01" DateCreated="2015-03-24" Type="SCV" Version="7" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10498896</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10922411</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11156381</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11319798</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12072543</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15146471</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16905682</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17047042</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20526219</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24935963</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25803691</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25813228</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27287845</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8653684</ID>
          </Citation>
          <Comment>The c.335_337dupGTC pathogenic mutation (also known as p.R112dup) located in coding exon 2 of the CDKN2A gene, results from an in-frame duplication of GTC between nucleotide positions 335 and 337. This results in the duplication of an arginine residue at codon 112. This alteration has been described as one of the most common CDKN2A mutations in Europe and as a founder mutation in the Swedish population (Borg et al. Cancer Res. 1996; 56(11): 2497-500; Goldstein AM et al. Cancer Res., 2006 Oct;66:9818-28;Goldstein AM. Hum. Mutat., 2004 Jun;23:630; Goldstein AM, J. Med. Genet. 2007 Feb; 44(2):99-106; Hashemi J, et al. Genes Chromosomes Cancer 2001 Jun; 31(2):107-16; Nielsen K et al. Melanoma Res., 2010 Aug;20:266-72; Helgadottir H et al. J. Natl. Cancer Inst., 2016 Nov;108:). This alteration is located in the functionally-important ankyrin repeat region and has been shown to result in loss of binding capacity for cdk4 and cdk6 in vitro (Ruas M, et al. Oncogene 1999 Sep; 18(39):5423-34; Borg A, J. Natl. Cancer Inst. 2000 Aug; 92(15):1260-6). Based on a study of 28 Swedish families with the c.335_337dupGTC mutation, carriers are estimated to have increased relative risk compared to non-carrier controls for melanoma (RR = 64.8) and pancreatic cancer (RR = 43.8), as well as malignancies of the upper digestive (RR = 17.1) and respiratory tract (RR = 15.6) (Helgadottir H, et al. J. Med. Genet. 2014 Aug; 51(8):545-52). Overall risks for these cancer types were increased further for ever-smoker carriers compared to never-smoker carriers in this study (OR = 9.3). Of note, this alteration is also known as p.R112_L113insR, p.Arg105ins, 113insArg, and 337-338insGTC in published literature. Based on the available evidence, this alteration is classified as a pathogenic mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CDKN2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000077.4:c.335_337dupGTC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
          <SubmissionName>NonExomeUpdate_081220AmbryReport</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2657335" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="383849" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="561381" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7910661" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7865311" TraitType="Disease" MappingType="XRef" MappingValue="155755" MappingRef="OMIM">
        <MedGen CUI="C1835042" Name="Melanoma and neural system tumor syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="538667" TraitType="Disease" MappingType="XRef" MappingValue="C1512419" MappingRef="MedGen">
        <MedGen CUI="C1512419" Name="Familial melanoma" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

